Skip to main content

EpiPen makers pay $625K to state over 'misleading' TV ads

The two companies who make and market the EpiPen will pay the state of Massachusetts $625,000 to settle charges that they overstated the effectiveness of the product in treating acute allergic reactions in a commercial...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.